An Increase in Total Deaths Per Million Associated with COVID-19 Due Directly to the Causal Impact of Vaccination Initiation By Brian Simpson

Statistics indicate that there are an estimated 145 countries experiencing an “increase in total deaths per million associated with COVID-19 due directly to the causal impact of [vaccination] initiation.” This is according to a study conducted by the University of Alberta in Canada. Highly vaccinated countries such as Taiwan, Mongolia, Cambodia and Thailand, which had the lowest numbers of Covid-related deaths at the beginning of the pandemic, now have among the highest number of cases. The conclusion of the study is that the Covid vaccines have had a limited role at present in lowering Covid cases. What is not considered is whether or not we are seeing ADE (Antibody Dependent Enhancement) occurring due to the vaccines. Time will definitely tell.

https://www.naturalnews.com/2022-01-25-covid-vaccine-rollout-rise-in-deaths.html

“A study conducted by the University of Alberta in Canada showed data from 145 countries that revealed a worrisome link between Wuhan coronavirus (COVID-19) vaccine rollout and the increased number of deaths.

In the United States alone, COVID vaccine rollouts appear to have increased the number of COVID cases per million by nearly 40 percent. Introducing the shots during an active pandemic also increased the number of COVID-related deaths by 31 percent per million.

Other countries have not fared well, either, with an estimated 145 countries experiencing an “increase in total deaths per million associated with COVID-19 due directly to the causal impact of [vaccination] initiation.”

Countries like Taiwan, Mongolia, Cambodia and Thailand, which had the lowest numbers of COVID-related deaths at the beginning of the pandemic, now fared the worst.

According to the study, the data indicated a marked increase in both COVID-19-related cases and death due to vaccine deployment. Lead author Kyle Beattie also said that the effect of the vaccines on total cases per million and its low positive association with total vaccinations per hundred signify the limited impact of vaccines in lowering cases.

He went on to say that the results should encourage local policymakers to make decisions based on data, not narrative, and based on local conditions, not global or national mandates. These data, he said, should encourage them to begin looking for other avenues other than mass vaccination campaigns.

There are others that claim Beattie’s study has “flawed reasoning” and failed to properly account for confounding variables that could influence cases and deaths, such as viral variants and healthcare capacity. However, Beattie stands by his analysis, saying that the overwhelmingly positive causal impact after vaccine deployment on the dependent variables of total deaths and total cases per million should be highly worrisome for policymakers.

Vaccination protection wanes over time

In November 2021, a separate study found that there was a gradual increase in the risk of COVID-19 infections from 90 days after receiving a second dose of the Pfizer vaccine. The study was carried out by the Research Institute of Leumit Health Services in Israel.

The findings confirmed that the vaccine, which provided “excellent” protection in the initial weeks after vaccination, suggested that protection wanes over time. Despite large-scale vaccination campaigns set to help control the spread of the virus, breakthrough infections may still occur.

Examining the time elapsed since the vaccination and the risk of infection could provide important clues regarding the need for third or fourth injections and the preferred timing.

The researchers acknowledge that the interpretation of findings is limited by observational design, and there is no way to rule out the possibility that other factors could affect the outcomes.

Further, most medical experts no longer consider a fourth dose necessary, as it could offer less protection against omicron, according to preliminary data. The data, which came from Sheba Hospital, delivered fourth doses of vaccines to over 270 members of its staff, who previously received either Pfizer or Moderna shots.

Dr. Gili Regev-Yochay, the director of the infection prevention and control unit of the hospital, said that despite the increased antibody levels, the fourth vaccine only offers partial defense against the virus.

These results raised questions about Israel’s decision to offer a second booster shot to its over-60 population, as the government already recorded over 500,000 people receiving their second booster in recent weeks. (Related: GLOBAL ALERT: An estimated 10 million people PER DAY are set on irreversible countdown to vaccine death that could exterminate BILLIONS if not stopped in the next year.)

Dr. Nahman Ash, the director of the Health Ministry in Israel said that the research findings did not mean that the fourth vaccination was a mistake, as it returns the level of antibodies to what it was at the beginning of the third dose. “That has great importance, especially among the older population,” he said.”